⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for galunisertib

Every month we try and update this database with for galunisertib cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
A Study of Galunisertib (LY2157299) in Combination With Nivolumab in Advanced Refractory Solid Tumors and in Recurrent or Refractory NSCLC, or Hepatocellular CarcinomaNCT02423343
Solid Tumor
Non-Small Cell ...
Hepatocellular ...
Galunisertib
Nivolumab
18 Years - Eli Lilly and Company
A Study of Galunisertib on the Immune System in Participants With CancerNCT02304419
Neoplasm
Galunisertib
18 Years - Eli Lilly and Company
A Study of Galunisertib (LY2157299) in Combination With Nivolumab in Advanced Refractory Solid Tumors and in Recurrent or Refractory NSCLC, or Hepatocellular CarcinomaNCT02423343
Solid Tumor
Non-Small Cell ...
Hepatocellular ...
Galunisertib
Nivolumab
18 Years - Eli Lilly and Company
A Study in Metastatic Cancer and Advanced or Metastatic Unresectable Pancreatic CancerNCT01373164
Neoplasms
Neoplasm Metast...
Pancreatic Canc...
Galunisertib
Gemcitabine
Placebo
18 Years - Eli Lilly and Company
A Study of Galunisertib (LY2157299) and Durvalumab (MEDI4736) in Participants With Metastatic Pancreatic CancerNCT02734160
Metastatic Panc...
Galunisertib
Durvalumab
18 Years - Eli Lilly and Company
Paclitaxel/Carboplatin + Galunisertib for Patients With Carcinosarcoma of the Uterus or OvaryNCT03206177
Carcinosarcoma,...
Galunisertib
Paclitaxel
Carboplatin
18 Years - 99 YearsUniversity of Oklahoma
Galunisertib and Capecitabine in Advanced Resistant TGF-beta Activated Colorectal CancerNCT03470350
Colorectal Canc...
Galunisertib
18 Years - The Netherlands Cancer Institute
Galunisertib and Capecitabine in Advanced Resistant TGF-beta Activated Colorectal CancerNCT03470350
Colorectal Canc...
Galunisertib
18 Years - The Netherlands Cancer Institute
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: